TABLE OF CONTENTS. 1. Introduction Dementia and Alzheimer Prevalence. 2. Global Alzheimer Market and Performance. 2.1.

Size: px
Start display at page:

Download "TABLE OF CONTENTS. 1. Introduction. 1.1. Dementia and Alzheimer Prevalence. 2. Global Alzheimer Market and Performance. 2.1."

Transcription

1 1

2 Disclaimer The research reports provided by AM Mindpower Solutions are for the personal information of the authorised recipient and is not for public distribution and should not be reproduced or redistributed without prior permission. You are permitted to print or download extracts from this material for your personal use only. None of this material may be used for any commercial or public use. The information provided in the research documents is from publicly available data and other sources, which are reliable. Efforts are made to try and ensure accuracy of data. With respect to documents available, neither the company nor any of its employees makes any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. The report also includes analysis and views expressed by our research team. The research reports are purely for information purposes. The opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. Investors should not solely rely on the information contained in the research documents and must make investment decisions based on their own investment objectives, risk profile and financial position. The recipients of this material should take their own professional advice before acting on this information. No part of this manual or any material appearing may be reproduced, stored in or transmitted on any other Web site without written permission of AM Mindpower Solutions and any payments of a specified fee. Requests to republish any material may be sent to us. 2

3 TABLE OF CONTENTS 1. Introduction 1.1. Dementia and Alzheimer Prevalence 2. Global Alzheimer Market and Performance 2.1. Market Size 2.2. Alzheimer Drugs Demand 3. Alzheimer s Market: United States 3.1. Prevalence of the Disease 3.2. Market Size US Alzheimer Drugs Market 4. China 5. Industry Trends 5.1. Ranbaxy gets Approval for Alzheimer s drug 5.2. Wockhardt received US FDA approval for Alzheimer s drug Memantine 5.3. Opportunities Persist in the Global Market 5.4. Canada A New Destination for Alzheimer Treatment 5.5. RFID Chip Implants Planned for Alzheimer's Patients 5.6. Herbal supplement improves memory in patients at risk of Alzheimer's 5.7. Scientists Develop Blood Test to Detect Alzheimer's disease 5.8. Government Regulation 5.9. Future Outlook 6. Driving Forces 6.1. Prevalence Rate Increases with Aging Population 3

4 6.2. Urbanization is More Prone to the Risk of Dementia 6.3. Western Regions Shows higher Risk than Eastern Parts 7. Competitive Landscape 7.1. Drugs Competition 7.2. Market Players Profile Forest Laboratories Novartis Elan Corporation 4

5 LIST OF FIGURES Figure 1: Cost of Dementia and Comparison With Company s Revenues Figure 2: Global Alzheimer Market by Value ( ) Figure 3: Global Alzheimer Drugs Market Share in 2009 Figure 4: Lifetime Risks for Alzheimer s by Age and Sex Figure 5: US Alzheimer Therapeutic Market ( E) Figure 6: Medicine Market Share in China in 2010 Figure 7: Projected Number of people Aged 65 and Over in US Population with Alzheimer Disease Figure 8: Global Alzheimer therapeutic Market Forecast by Value ( E) Figure 9: Alzheimer Prevalence Rate in Aging Population LIST OF TABLES Table 1: Global Alzheimer Drugs Sales in 2009 Table 2: Alzheimer Therapeutic Drugs Market in US ( ) Table 3: Expected Bapineuzumab Sales ( E) Table 4: Alzheimer Drugs Comparison Table 5: Clinical Trials Table 6: Forest Laboratories Revenues by Business Segments Table 7: Novartis Revenue and Operating Income ( ) Table 8: Elan Revenues by Business Segments 5

6 GLOBAL ALZHEIMER MARKET AND PERFORMANCE The global Alzheimer's disease therapeutics market was valued at USD~billion in The Galantamine drug patent expired in By geography, North America is heading the market with 37.73% share of the global Alzheimer market in Figure: Global Alzheimer Market by Value ( ) USD Billion The leading markets for Alzheimer disease therapeutics were United States, Europe, and Japan accounting for a large share of the overall market. Eisai/Pfizer and Aricept demand also contributed in the growth. ALZHEIMER DRUGS DEMAND After cardiovascular disease and cancer AD is the third largest market in the world in terms of cost to treat the disease. The top 5 pharmaceutical companies in this market are Eisai, Forest Pharmaceutical, Novartis, Pfizer, and Johnson & Johnson. Figure: Global Alzheimer Drugs Market Share in 2009 Namenda Razadyne Exeion Aricept Others 6

7 In 2009, Namenda market share has reached to ~% from ~% in Aricept accounted for the royal share of the market (~%), Exelon and razadyne accounted for ~% and ~% market share in Table: Global Alzheimer Drugs Sales in 2009 Drug Name Generic Name Marketed Approved Sales 2009 Namenda Memantine HCL Forest Labs 2003 Razadyne Galantamine J&J 2001 Exelon Rivastigmine Novartis 2000 Aricept Donepezil Pfizer and Eisai 1996 Cognex Tacrine Generic

8 ALZHEIMER S MARKET: UNITED STATES United States is the largest market for Alzheimer drugs and treatment accounting for USD~ billion in Eisai/Pfizer s Aricept (donepezil) and Forest pharmaceutical s Namenda (memantine) are the market leaders in the region. In 2010 Alzheimer market reached to USD~ billion from USD~ billion in US Alzheimer market has also faced the heat of economic recession with decline in number of hospital patients or regular treatment but due to the need of the treatment it settled down with a slight change in growth rates. Figure: US Alzheimer Therapeutic Market ( E) USD Billion E US ALZHEIMER DRUGS MARKET Aricept had annual sales of USD~ billion in the US in 2010 Namenda achieved sales of USD~ billion in 2010 from USD~ million in 2009 and Razadyne ER has annual sale was USD~ million in the same year. Table: Alzheimer Therapeutic Drugs Market in US ( ) Aricept Namenda Exelon Razadyne Razadyne ER Total Others Total 8

9 CHINA China is emerging as one of the most important markets for growth for the pharmaceutical industry as the Chinese government is in the midst of expanding the access to healthcare in the country. The diagnosis and drug treatment of Alzheimer's disease in China is extremely low, especially in rural regions. Rural cases of Alzheimer's disease account for approximately 62% percent of the prevalent Alzheimer's disease population in China. Huperzine A (Chinese brands) and donepezil (Eisai's Aricept, Chinese brands) are two leading drugs dominating the treatment of Alzheimer's disease and the overall Alzheimer's disease market in China constituted around USD~ million in Figure: Medicine Market Share in China in 2010 Huperzine A and Donepezil Others 9

10 FUTURE OUTLOOK The Alzheimer s Association estimates that total U.S. payments for health and long-term care services for people with these conditions will amount to USD~ billion from all sources in Nearly 11 million U.S. family members and other unpaid caregivers provided care for people with Alzheimer s and other dementias, valued at USD~ billion. The AD market could cross USD~ billion by 2016 with the introduction of disease-modifying drugs (DMDs). AD is likely to be the primary driver of growth in the larger central nervous system market from 2005 to 2011, expected to grow with a compound annual growth rate (CAGR) of 1.21% due to expiry of some major drugs, introduction of new therapeutic treatment and incurable disease fluctuates the demand trends. Figure: Global Alzheimer therapeutic Market Forecast by Value ( E) USD Billion E 2012E 2013E 2014E 2015E 10

11 Table: Expected Bapineuzumab Sales ( E) US Alzheimer s Treatment Market (MM) 2010E 2011E 2012E 2013E 2014E 2015E US Population Yr old US Population 85+ Yr old US Alzheimer s Sufferers (MM) Percent Treated AD Patients Treated (MM) % Mild/Moderate AD Mild/Moderate Patients treated (MM) Development Status Pll/Filing Launch New patients ( 000) Total patients % of total treated patients % of Mild/Moderate patients treated It is expected that the growth of all the currently available agents will decline in future due to a combined effect of generic entry and competition from newly emerging agents. 11

Alzheimer s Disease 2009. Alzheimer s Disease. Markets, Pipeline and Opportunities. April 2009. By John Bates Ph.D. 1 Copyright 2009 Biopharm Reports

Alzheimer s Disease 2009. Alzheimer s Disease. Markets, Pipeline and Opportunities. April 2009. By John Bates Ph.D. 1 Copyright 2009 Biopharm Reports Alzheimer s Disease Markets, Pipeline and Opportunities April 2009 By John Bates Ph.D 1 About the Author John Bates is a consultant and author in the drug markets and R&D fields. After a first degree in

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS List of Figures List of Tables 1. Qatar Online Advertising Market Size and Introduction, 2007-2012 2. Qatar Online Advertising Market Revenue Models, 2012 3. Qatar Online Advertising

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied TABLE OF CONTENTS 1. The US Orthopedic Implants and Devices Market Introduction 2. The US Orthopedic Implants and Devices Market Value Chain 3. The US Orthopedic Implants and Devices Market Size, 2008-2013

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. Qatar Health and Wellness Market Introduction 2. Qatar Health and Wellness Market Size, 2006-2012 3. Qatar Health and Wellness Market Segmentation, 2006-2012 4. Qatar Cosmetics and

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. India Video Games Industry Introduction 1.1. India Video Games Industry Value Chain 1.2. India Video Games Industry Production Process 2. India Video Games Industry Size by Revenues,

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. Global Telemedicine Market Introduction 2. Global Telemedicine Market Size, 2006-2013 3. Global Telemedicine Market Segmentation 3.1. By Telehome and Telehospital, 2006-2013 4. The

More information

1.4. North America Life and Non-Life Insurance Market Size by Value, 2001-2015

1.4. North America Life and Non-Life Insurance Market Size by Value, 2001-2015 TABLE OF CONTENTS 1. North America Insurance Market 1.1. North America Insurance Market Introduction 1.2. North America Insurance Market Drivers 1.3. North America Insurance Market Restraints 1.4. North

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. UAE Online Advertising Market Size and Introduction, 2007-2012 2. UAE Online Advertising Market Revenue Models, 2012 3. UAE Online Advertising Market Segmentation by Type of Industry,

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. The US E-learning Market Introduction 2. The US E-learning Market Size, 2007-2012 3. The US E-learning Market Segmentation by Users, 2007-2012 3.1. The US K-12 E-learning Market

More information

Staging and Treatment of Dementia

Staging and Treatment of Dementia Staging and Treatment of Dementia Ami Hall DO 10/25/14 1 Objectives What are the two most common types of dementias seen in a primary care office How are they staged What treatments are available Definition

More information

DRUG APPROVAL PROCESS FOR THE TREATMENT OF ALZHEIMER S DISEASE

DRUG APPROVAL PROCESS FOR THE TREATMENT OF ALZHEIMER S DISEASE Research DRUG APPROVAL PROCESS FOR THE TREATMENT OF ALZHEIMER S DISEASE There are certain principles that should be followed when involving people with Alzheimer s disease in research. For more information,

More information

2. China Life and Non-Life Insurance Market Size by Value, 2008-2015

2. China Life and Non-Life Insurance Market Size by Value, 2008-2015 TABLE OF CONTENTS 1. China Insurance Market Introduction 2. China Life and Non-Life Insurance Market Size by Value, 2008-2015 3. China Life and Non-Life Insurance Density, Premium per Capita, USD, 2001-2015

More information

2.1. Number of Insurance Companies in Portugal, 2001-2009 2.2. Headcount in Portugal Insurance Sector, 2001-2009

2.1. Number of Insurance Companies in Portugal, 2001-2009 2.2. Headcount in Portugal Insurance Sector, 2001-2009 TABLE OF CONTENTS 1. Portugal Insurance Market Introduction 2. Portugal Insurance Market Structure 2.1. Number of Insurance Companies in Portugal, 2001-2009 2.2. Headcount in Portugal Insurance Sector,

More information

Alzheimer s Disease. Leveraging Multiple Data Sources to Maximize the Potential for Recruitment Success. By Loni Branon

Alzheimer s Disease. Leveraging Multiple Data Sources to Maximize the Potential for Recruitment Success. By Loni Branon Alzheimer s Disease Leveraging Multiple Data Sources to Maximize the Potential for Recruitment Success By Loni Branon A2 March 2016 Leveraging Multiple Data Sources to Maximize the Potential for Recruitment

More information

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014 Asia-Pacific Interventional Cardiology Procedures Outlook to 2020 Reference Code: GDMECR0061PDB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2

More information

2. Italy Life and Non-Life Insurance Market Size by Value, 2001-2015

2. Italy Life and Non-Life Insurance Market Size by Value, 2001-2015 TABLE OF CONTENTS 1. Italy Insurance Market Introduction 2. Italy Life and Non-Life Insurance Market Size by Value, 2001-2015 3. Italy Life and Non-Life Insurance Density, Premium Per Capita, USD, 2001-2015

More information

Donepezil, galantamine, rivastigmine and memantine for Alzheimer s disease

Donepezil, galantamine, rivastigmine and memantine for Alzheimer s disease Understanding NICE guidance Information for people who use NHS services Donepezil, galantamine, rivastigmine and memantine for Alzheimer s disease NICE technology appraisal guidance advises on when and

More information

US Diabetic Devices Industry Research Report: KenResearch

US Diabetic Devices Industry Research Report: KenResearch US Diabetic Devices Industry Research Report: KenResearch by KenResearch - Monday, February 24, 2014 https://www.kenresearch.com/blog/2014/02/us-diabetic-devices-industry-research-report-kenresearch/ The

More information

Alzheimer Disease (AD)

Alzheimer Disease (AD) 1 Alzheimer Disease (AD) 2 Alzheimer's disease is a progressive degenerative disease that attacks the brain and results in impaired memory, thinking and behavior. It was first described by Dr. Alois Alzheimer

More information

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?

More information

Being an advocate for good care. Useful medications What to expect When to be concerned

Being an advocate for good care. Useful medications What to expect When to be concerned Being an advocate for good care Useful medications What to expect When to be concerned Common Medical Questions 1. What medications are available to help with memory loss? Cholinesterase Inhibitors The

More information

全 球 多 发 性 硬 化 症 治 疗 市 场 研 究 报 告 Multiple Sclerosis Therapeutics - A Global Strategic Business Report

全 球 多 发 性 硬 化 症 治 疗 市 场 研 究 报 告 Multiple Sclerosis Therapeutics - A Global Strategic Business Report /wepdwukltuyot 全 球 多 发 性 硬 化 症 治 疗 市 场 研 究 报 告 Multiple Sclerosis Therapeutics - A Global Strategic Business Report 联 系 购 买 电 话 :010-82863480 公 司 名 称 : 佐 思 信 息 公 司 地 址 : 北 京 市 海 淀 区 苏 州 街 18 号 院 长 远 天

More information

U.S. Scientific Update Aricept 23 mg Tablets. Dr. Lynn Kramer President NeuroScience Product Creation Unit Eisai Inc.

U.S. Scientific Update Aricept 23 mg Tablets. Dr. Lynn Kramer President NeuroScience Product Creation Unit Eisai Inc. U.S. Scientific Update Aricept 23 mg Tablets Dr. Lynn Kramer President NeuroScience Product Creation Unit Eisai Inc. Unmet Need in Moderate to Severe Alzheimer s Disease (AD) Ongoing clinical deterioration

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. India Electronic Security Market Introduction 2. India Electronic Security Market Value Chain 3. India Electronic Security Market Size by Value, FY 2008 FY 2013 4. India Electronic

More information

3. Total Foreign Patients Treated and Foreign Patients Revenue in Malaysia, Medical Tourism Treatment Cost Comparison, 2010

3. Total Foreign Patients Treated and Foreign Patients Revenue in Malaysia, Medical Tourism Treatment Cost Comparison, 2010 TABLE OF CONTENTS 1. Medical Tourism in Malaysia An Overview 2. Medical Tourism Value Chain in Malaysia 3. Total Foreign Patients Treated and Foreign Patients Revenue in Malaysia, 2005-2010 4. Medical

More information

2. The UK Life and Non-Life Insurance Market Size by Value, 2001-2015

2. The UK Life and Non-Life Insurance Market Size by Value, 2001-2015 TABLE OF CONTENTS 1. The UK Insurance Market Introduction 2. The UK Life and Non-Life Insurance Market Size by Value, 2001-3. The UK Life and Non-Life Insurance Density, Premium Per Capita, USD, 2001-4.

More information

Multiple Sclerosis. Current and Future Players. GDHC1009FPR/ Published March 2013

Multiple Sclerosis. Current and Future Players. GDHC1009FPR/ Published March 2013 Multiple Sclerosis Current and Future Players GDHC1009FPR/ Published March 2013 Executive Summary Moderate Growth in the Multiple Sclerosis Market is Expected from 2012 2022 GlobalData estimates the 2012

More information

Opportunities in the China Healthcare Sector. December 2008

Opportunities in the China Healthcare Sector. December 2008 Opportunities in the China Healthcare Sector December 28 Opportunities in the China Healthcare Sector Executive Summary China s healthcare sector is rapidly developing Total Health expenditure in China

More information

2.1. Number of Insurance Companies in Poland, 2001-2009 2.2. Headcount in Poland Insurance Sector, 2001-2009

2.1. Number of Insurance Companies in Poland, 2001-2009 2.2. Headcount in Poland Insurance Sector, 2001-2009 TABLE OF CONTENTS 1. Poland Insurance Market Introduction 2. Poland Insurance Market Structure 2.1. Number of Insurance Companies in Poland, 2001-2.2. Headcount in Poland Insurance Sector, 2001-3. Poland

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

Global Market Study on Sleep Aids: Sleep Apnea to Witness Highest Growth by 2020

Global Market Study on Sleep Aids: Sleep Apnea to Witness Highest Growth by 2020 Brochure More information from http://www.researchandmarkets.com/reports/3422615/ Global Market Study on Sleep Aids: Sleep Apnea to Witness Highest Growth by 2020 Description: Sleep aids are pills and

More information

3. Turkey Life and Non-Life Insurance Market Size by Value, 2001-2015

3. Turkey Life and Non-Life Insurance Market Size by Value, 2001-2015 TABLE OF CONTENTS 1. Turkey Insurance Market Introduction 2. Turkey Insurance Market Structure 2.1. Number of Insurance Companies in Turkey, 2001-2009 2.2. Headcount in Turkey Insurance Sector, 2001-2009

More information

Brain Signal Analysis Software Market Outlook to 2017

Brain Signal Analysis Software Market Outlook to 2017 Brain Signal Analysis Software Market Outlook to 2017 published: Nov 2013 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system

More information

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010 U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade December 2010 Table of Contents Notes on Methodology 8 Market Introduction and Segmentation Introduction

More information

Brochure More information from http://www.researchandmarkets.com/reports/3292678/

Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long

More information

Pharmacotherapy of BPSD. Pharmacological interventions. Anti-dementia drugs. Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence

Pharmacotherapy of BPSD. Pharmacological interventions. Anti-dementia drugs. Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence Pharmacotherapy of BPSD Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence Pharmacological interventions Reducing medication errors. Reducing potentially inappropriate medication prescription.

More information

Donepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease

Donepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease IS 11 October 2011 Information sheet Donepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease Introduction... 1 How does Aricept work?... 1 Who might benefit from Aricept?... 2 What effect

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. India Dental Care Services Industry Introduction 2. India Dental Care Services Market Size by Revenue, 2008-2013 3. India Dental Care Services Market Segmentation 3.1. By Types of

More information

Update on Treatment of the Dementias

Update on Treatment of the Dementias Update on Treatment of the Dementias Mark Pippenger, MD Behavioral Neurology Associate Clinical Professor of Neurology University of Arkansas for Medical Sciences Disclosures I will be discussing off-label

More information

Non-pharmacological Approach to the Alzheimer s Disease Patient

Non-pharmacological Approach to the Alzheimer s Disease Patient Non-pharmacological Approach to the Alzheimer s Disease Patient Dr. DeeDee Hu, PharmD National Council of Certified Dementia Practitioners Objectives Copyright 2009, National Council of Identify pitfalls

More information

Cellular Therapy and Cord Blood Market Report 2013 Page 1. Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences

Cellular Therapy and Cord Blood Market Report 2013 Page 1. Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences Cellular Therapy and Cord Blood Market Report 2013 Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences k.gray@selectbio.com Select Biosciences Market Reports Website: SelectBiosciences.com/marketreports/

More information

This is a licensed product of AM Mindpower Solutions and should not be copied

This is a licensed product of AM Mindpower Solutions and should not be copied 1 TABLE OF CONTENTS 1. The US Health Insurance Industry Introduction 2. The US Health Insurance Industry Value Chain Government Health Programs Private Health Programs. 3. The US Regulations Pertaining

More information

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease 2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease Dylan Wint, M.D. ALZHEIMER DISEASE Dylan Wint, M.D. Lou Ruvo Center for Brain Health DEFINITIONS Cognitive related to thinking,

More information

The Future of R&D Outsourcing

The Future of R&D Outsourcing OUTSOURCING The Future of R&D Outsourcing Investigating development hurdles, key challenges & strategies to optimize CRO relationships By Alison Sahoo Alison Sahoo Alison Sahoo is a pharmaceutical industry

More information

For personal use only

For personal use only MedAdvisor MedAdvisor improves health outcomes, placing patients at the centre of connected health platforms 2 Important Notice COMMERCIAL IN CONFIDENCE This Presentation is dated 16 November 2015 and

More information

Memantine (Ebixa) Drug treatment for Alzheimer s disease

Memantine (Ebixa) Drug treatment for Alzheimer s disease IS 20 October 2011 Information sheet Memantine (Ebixa) Drug treatment for Alzheimer s disease Introduction... 1 How does Ebixa work?... 1 Who might benefit?... 2 What effect might Ebixa have?... 2 How

More information

Healthcare. 2015 AV Vertical Markets. Corporate Education Government Retail Hospitality. Venues. Global End-User Perspective

Healthcare. 2015 AV Vertical Markets. Corporate Education Government Retail Hospitality. Venues. Global End-User Perspective 2015 AV Vertical Markets Global End-User Perspective Corporate Education Government Retail Hospitality Healthcare Venues 1.800.659.7469 +1.703.273.7200 infocomm.org/marketresearch Copyright 2015 InfoComm

More information

Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs

Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs Brochure More information from http://www.researchandmarkets.com/reports/706246/ Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs Description: Only about 36% of Multiple Sclerosis (MS)

More information

Healthcare, Regulatory and Reimbursement Landscape - Australia

Healthcare, Regulatory and Reimbursement Landscape - Australia Brochure More information from http://www.researchandmarkets.com/reports/2207850/ Healthcare, Regulatory and Reimbursement Landscape - Australia Description: Healthcare, Regulatory and Reimbursement Landscape

More information

REFERENCE CODE GDHC269DFR PUBLICATION DATE JULY 2013 PREMARIN (POSTMENOPAUSAL VAGINAL ATROPHY) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC269DFR PUBLICATION DATE JULY 2013 PREMARIN (POSTMENOPAUSAL VAGINAL ATROPHY) - FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC269DFR PUBLICATION DATE JULY 2013 PREMARIN Executive Summary Premarin (conjugated estrogen cream): Key Metrics in the Seven Major Pharmaceutical Markets 2012 Market Sales US 5EU Japan

More information

Medical Equipment Monthly Deals Analysis: January 2015- M&A and Investment Trends

Medical Equipment Monthly Deals Analysis: January 2015- M&A and Investment Trends Medical Equipment Monthly Deals Analysis: January 2015- M&A and Investment Trends Reference Code: GDME0470MD Publication Date: March 2015 Independent Medical Equipment Research M&A Trends and Analysis

More information

TABLE OF CONTENTS. 1. China Online Advertising An Overview Online advertising revenue models. CPM (cost per thousand) Click Through Rate

TABLE OF CONTENTS. 1. China Online Advertising An Overview Online advertising revenue models. CPM (cost per thousand) Click Through Rate TABLE OF CONTENTS 1. China Online Advertising An Overview 1.1. Online advertising revenue models CPM (cost per thousand) Click Through Rate 2. Market Size Performance in Pre-recessionary period Performance

More information

R e p o r t D e s c r i p t i o n. T a b l e o f C o n t e n t s. L i s t o f T a b l e s. S a m p l e T a b l e s. R e l a t e d R e p o r t s

R e p o r t D e s c r i p t i o n. T a b l e o f C o n t e n t s. L i s t o f T a b l e s. S a m p l e T a b l e s. R e l a t e d R e p o r t s PH 1618 $4650 2011 U.S. ELECTRONIC MEDICAL RECORDS (EMR - PHYSICIAN OFFICE & HOSPITAL) MARKET Emerging Trends (Smart Cards, Speech Enabled EMR), Market Share, Winning Strategies, Adoption & Forecasts Till

More information

Global Multiple Sclerosis Market: Trends and Opportunities (2013-18)

Global Multiple Sclerosis Market: Trends and Opportunities (2013-18) Global Multiple Sclerosis Market: Trends and Opportunities (2013-18) Scope of the Report The report titled Global Multiple Sclerosis Market: Trends & Opportunities (2013-18) provides an insight into the

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive pressures through to 2019

Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive pressures through to 2019 Brochure More information from http://www.researchandmarkets.com/reports/1314569/ Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive

More information

Why Are Drugs So Expensive? Learning About the Drug Development Process

Why Are Drugs So Expensive? Learning About the Drug Development Process Why Are Drugs So Expensive? Page 1 of 92 Why Are Drugs So Expensive? Learning About the Drug Development Process written by: Ann Newman Seventh Street Development Group This product is for your Personal

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

RNCOS KSA Steel Industry Forecast 2015 Online Business Research

RNCOS KSA Steel Industry Forecast 2015 Online Business Research RNCOS Page 1 1. Analyst View The Saudi Arabia's economy, the largest economy among the Arab countries and has one of the largest construction industries in the Middle-east region. Backed by an everincreasing

More information

NORTH AMERICA HEALTHCARE CLOUD COMPUTING MARKET

NORTH AMERICA HEALTHCARE CLOUD COMPUTING MARKET NORTH AMERICA HEALTHCARE CLOUD COMPUTING MARKET [By Applications (EMR, PACS, RIS, RCM, APB), By Deployment (Private, Public, Hybrid), By Service (SaaS, IaaS), By Pricing (Pay-As-You- Go, Spot), By End

More information

MEDICAL WASTE MANAGEMENT MARKET

MEDICAL WASTE MANAGEMENT MARKET MEDICAL WASTE MANAGEMENT MARKET BY SECTOR (Hospital & Pharmaceutical), SERVICE (Collection, Transportation & Storage, Treatment, Disposal & Recycling), TREATMENT TECHNOLOGY (Mechanical, Thermal, Chemical,

More information

REFERENCE CODE GDHCER032-14 PUBLICAT ION DATE AUGUST 2014 RENAL CELL CARCINOMA - EPIDEMIOLOGY FORECAST TO 2023

REFERENCE CODE GDHCER032-14 PUBLICAT ION DATE AUGUST 2014 RENAL CELL CARCINOMA - EPIDEMIOLOGY FORECAST TO 2023 REFERENCE CODE GDHCER032-14 PUBLICAT ION DATE AUGUST 2014 RENAL CELL CARCINOMA - Executive Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted

More information

2011-2015. Sample-Global Big Data Market in the Healthcare Sector. technavio insights

2011-2015. Sample-Global Big Data Market in the Healthcare Sector. technavio insights 1 technavio insights About TechNavio Technavio is the research platform of Infiniti Research. Infiniti Research provides actionable market intelligence to leading companies worldwide. A team of 120 analysts

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com https://marketpublishers.com

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com https://marketpublishers.com North American Home Healthcare Market, By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. Asia-Pacific Insurance Industry 1.1. Industry Introduction 1.2. Asia-Pacific Insurance Market Size by Direct Written Premium, 2005-2012P 1.3. Asia-Pacific Insurance Market Segmentation

More information

World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments

World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments Brochure More information from http://www.researchandmarkets.com/reports/836340/ World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments Description: World Vaccines Market 2008-2013:

More information

INDUSTRY OVERVIEW SOURCE OF INFORMATION. Report prepared by Euromonitor

INDUSTRY OVERVIEW SOURCE OF INFORMATION. Report prepared by Euromonitor The information that appears in this Industry Overview has been prepared by Euromonitor International Limited and reflects estimates of market conditions based on publicly available sources and trade opinion

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

Persistence Market Research

Persistence Market Research Persistence Market Research Global Obesity Surgery Devices Market Will Reach $2,489.5 Million in 2020 - Persistence Market Research Persistence Market Research 1 Persistence Market Research Released New

More information

REFERENCE CODE GDHC503DFR PUBLICAT ION DATE DECEMBER 2014 METHOTREXATE (RHEUMATOID ARTHRITIS) - FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC503DFR PUBLICAT ION DATE DECEMBER 2014 METHOTREXATE (RHEUMATOID ARTHRITIS) - FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC503DFR PUBLICAT ION DATE DECEMBER 2014 METHOTREXATE (RHEUMATOID ARTHRITIS) - Executive Summary The table below provides the key metrics for Methotrexate in the 10MM (US, France, Germany,

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)

Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018) Brochure More information from http://www.researchandmarkets.com/reports/2693611/ Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018) Description: The report titled 'Global Rheumatoid

More information

Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth

Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth Brochure More information from http://www.researchandmarkets.com/reports/2640803/ Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine

More information

Executive Summary: Electric Vehicle Market Forecasts

Executive Summary: Electric Vehicle Market Forecasts RESEARCH REPORT Executive Summary: Electric Vehicle Market Forecasts Global Forecasts for Light Duty Hybrid, Plug-in Hybrid, and Battery Electric Vehicles: 2013-2020 NOTE: This document is a free excerpt

More information

GCC Pharmaceutical Industry

GCC Pharmaceutical Industry GCC Pharmaceutical Industry First coordination meeting for the pharmaceutical industry in the GCC and Yemen Dr. Aasim Qureshi 11 April 2011 Global Pharmaceuticals Industry The pharmaceutical industry is

More information

Dementia. Your medicine. Information for you. Follow us on Twitter @NHSaaa Find us on Facebook at www.facebook.com/nhsaaa

Dementia. Your medicine. Information for you. Follow us on Twitter @NHSaaa Find us on Facebook at www.facebook.com/nhsaaa Dementia Your medicine Information for you Follow us on Twitter @NHSaaa Find us on Facebook at www.facebook.com/nhsaaa Visit our website: www.nhsaaa.net All our publications are available in other formats

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

Implication of China 2012 NEDL. Presented by: Li Xingwei Yong Hueyling

Implication of China 2012 NEDL. Presented by: Li Xingwei Yong Hueyling Implication of China 2012 NEDL to MNC pharma players Presented by: Li Xingwei Yong Hueyling Content Brief introduction of China NEDL policy China hospital system & MNCs Business Focus Influence of 2012

More information

TERM SHEET EXAMPLE. 1 P age

TERM SHEET EXAMPLE. 1 P age 1 P age TERM SHEET EXAMPLE BIOTECHCO Overview & Business Strategy BIOTECHCO (the licensor), located in North Dakota, has a proprietary technology called ZIP that can generate fully human antibodies with

More information

DATA CENTER NETWORKING MARKET

DATA CENTER NETWORKING MARKET DATA CENTER NETWORKING MARKET Ethernet Switches; SAN; Routers; ADC; Network Security Equipment; WAN Optimization Appliances Global Advancements, Worldwide Forecasts and Analysis (2013-2018) MarketsandMarkets

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information

India Diabetes Industry Research and Forecasts to FY'2016 - Shift towards Modern Insulin Delivery Devices

India Diabetes Industry Research and Forecasts to FY'2016 - Shift towards Modern Insulin Delivery Devices Brochure More information from http://www.researchandmarkets.com/reports/2118786/ India Diabetes Industry Research and Forecasts to FY'2016 - Shift towards Modern Insulin Delivery Devices Description:

More information

[Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)]

[Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)] [Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)] Executive Summary Stem Cells have a remarkable ability to develop in various body cells of a human. These occur in the earliest stages

More information

STATS WINDOW. INDUSTRY REVIEW AT A GLANCE Global Pharmaceutical Industry

STATS WINDOW. INDUSTRY REVIEW AT A GLANCE Global Pharmaceutical Industry Volume 6, Issue 6, December 2013 STATS WINDOW The Pacific Business Review International has taken an initiative to start a section which will provide a snapshot of major Global & Indian economic indicators

More information

Future Market Insights

Future Market Insights Global Bariatric Surgery Devices Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2015 Future Market Insights www.futuremarketinsights.com sales@futuremarketinsights.com

More information

6wresearch www.6wresearh.com sales@6wresearch.com

6wresearch www.6wresearh.com sales@6wresearch.com Cellular Machine to Machine (M2M) modules Market (2012-2017): Global Market Forecast by, M2M modules (GPRS, EDGE, CDMA 2000, UMTS/HSPA, WiMAX, LTE), Verticals (Utilities, Security, Automotive, Transport

More information

Overactive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Overactive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 Brochure More information from http://www.researchandmarkets.com/reports/3533933/ Overactive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 Description: SUMMARY The Report,

More information

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics

More information

RNCOS China Tourism Industry Forecast to 2012 Online Business Research

RNCOS China Tourism Industry Forecast to 2012 Online Business Research RNCOS Page 1 About Us RNCOS, formed in the year 2002, aims to outsource all your business needs and serve your customers in their quest for the information. RNCOS is transforming the concept of Outsourcing

More information

Brochure More information from http://www.researchandmarkets.com/reports/2639284/

Brochure More information from http://www.researchandmarkets.com/reports/2639284/ Brochure More information from http://www.researchandmarkets.com/reports/2639284/ Hospital Asset Management Market - Pharmaceutical (Wi-Fi RTLS, RFID, IR, Ultrasound, Equipment & Patient Tracking, Staff

More information

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample

MarketsandMarkets. http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm

More information